Living guidelines updates
The Stroke Foundation’s Clinical Guidelines for Stroke Management are evolving into the world's first living guidelines as the next generation of health evidence translation.
This three-year pilot project is building and evaluating a dynamically updating summary of stroke evidence to guide clinical practice and policy development.
Draft recommendations for public consultation
Based on new research evidence, our Guidelines Working Group has prepared draft recommendations to be submitted to the NHMRC for approval under section 14A of the National Health and Medical Research Council Act 1991. As part of the approval process, we are seeking submissions on the following draft recommendations.
Feedback or questions about the process can be submitted by email to email@example.com
|Topic||Consultation end date||Change|
|Thrombolysis||30/08/2019||New recommendations related to extending time window and use of tenecteplase.|
|Acute antithrombotic therapy||30/08/2019||Update to the recommendation for dual antiplatelet therapy for minor stroke and TIA.|
|Patent foramen ovale (PFO) management||30/08/2019||Update to the recommendation for percutaneous PFO closure.|
Recommendations with no changes
Based on searches for new research evidence up until 28 February 2019, our expert working groups have concluded that recommendations for the following topics in the Clinical Guidelines for Stroke Management 2017 are up-to-date.
How living guidelines work
The living guidelines use ‘evidence surveillance’ systems that continually scan for relevant new research, incorporate it into evidence summaries and rapidly update guideline recommendations whenever there is a substantial change in the evidence.
The ultimate goal is to create a near real-time, closed-loop evidence system in which global evidence and local data are integrated for insight and health decision making.
This work will be supported by new evidence systems from Cochrane Australia, including artificial intelligence, the Cochrane Crowd citizen science community, and the Covidence online systematic review platform.
Guideline recommendations will continue to be developed and published using the MAGICapp platform.
For the latest recommendations, see the Clinical Guidelines for Stroke Management.
For more information, please contact firstname.lastname@example.org
This project is a partnership between the Stroke Foundation and Cochrane Australia, and is supported by the Australian government’s Medical Research Future Fund.